The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. We manage technology for Cornell's Ithaca campus, Weill Cornell Medicine, Cornell Tech, and Cornell AgriTech in Geneva.
October 8, 2020
IGNITE is Cornell Research’s next generation gap funding program formerly known as the Cornell Technology Acceleration and Maturation (CTAM) Fund. The IGNITE program builds on CTAM’s success of providing... Read More
October 7, 2020
How do we increase investment into women entrepreneurs, and how can we help promote women into leadership roles? The Center for Technology Licensing (CTL) recently explored answering those questions... Read More
September 23, 2020
Traditionally, when graduating from a PhD program one looks to a career in academia, however, today the number of PhDs awarded greatly outpaces the number of available faculty positions created... Read More
September 21, 2020
Beckie Robertson ’82, Co-founder and Managing Director, Versant Ventures Beckie Robertson is a Managing Director specializing in early stage investing in medical devices and diagnostics at Versant. Beckie’s... Read More
September 9, 2020
Shockingly, only 12% of the inventors nationally are women. How do we go about improving our innovation ecosystem to increase the number of women faculty and graduate student inventors? ... Read More
August 14, 2020
The Center for Technology Licensing (CTL) at Cornell University launched a new site to showcase COVID-19 related innovations available for commercialization and opportunities to connect and collaborate with researchers. ... Read More
August 14, 2020
Invention Summary The invention disclosed contains any protective mask (N-95, surgical, cloth, etc.) combined with an HME filter for safe drinking with others when social distancing is not possible. ... Read More
August 6, 2020
Invention Summary Drug candidates to treat COVID-19 and a high throughput drug screening platform. Technology Overview The current COVID-19 pandemic has affected over 6 million people worldwide, has resulted in... Read More
August 6, 2020
Invention Summary Novel drug use and drug screening system for SARS-CoV-2 therapies. Technology Overview The outbreak of coronavirus disease COVID-19 caused by the novel SARS-CoV-2 virus has wreaked havoc... Read More
August 6, 2020
Invention Summary A platform of anti-inflammatory polymeric biomaterials that provides tunable immune responses via the modulation of macrophage metabolism. Technology Overview Macrophages (a type of white blood cell) produce... Read More